Smith & Nephew plc
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a SNN research report →
About the company
Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices and services in the United Kingdom, the United States, and internationally. The company operates in three segments: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management. It offers knee implant products for knee replacement procedures; hip implants for revision procedures; trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures; and other reconstruction products.
- CEO
- Deepak S Nath
- IPO
- 1999
- Employees
- 17,818
- HQ
- Watford, HRT, GB
Price Chart
- Market Cap
- $12.78B
- P/E
- 20.34
- P/S
- 2.02
- P/B
- 2.47
- EV/EBITDA
- 9.63
- Div Yield
- 2.58%
- Gross Margin
- 68.01%
- Op Margin
- 16.27%
- Net Margin
- 10.14%
- ROE
- 11.79%
- ROIC
- 9.11%
- Revenue
- $6.18B · 6.34%
- Net Income
- $626.46M · 52.05%
- EPS
- $1.46 · 55.32%
- Op Income
- $1.01B
- FCF YoY
- 40.92%
- 52W High
- $38.79
- 52W Low
- $28.56
- 50D MA
- $30.38
- 200D MA
- $33.25
- Beta
- 0.68
- Avg Volume
- 1.28M
Get TickerSpark's AI analysis on SNN
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Our SNN coverage
Recent articles, reports, and earnings notes.
No research on SNN yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate SNN report →Similar companies
Peers in the same neighborhood.